Literature DB >> 23319369

Aberrant cerebellar neurotrophin-3 expression induced by lipopolysaccharide exposure during brain development.

Ming Xu1, Elizabeth M Sajdel-Sulkowska, Toshiharu Iwasaki, Noriyuki Koibuchi.   

Abstract

Autism is a developmental disorder affecting communication, social interaction, motor skills, and cerebellar structure and functions. Recent studies have indicated that maternal infection during brain development may be one of the risk factors for autism. We have previously demonstrated the abnormal overexpression of neurotrophin-3 (NT-3) in autistic cerebellum. To examine further the potential link between autism and maternal infection, and specifically NT-3 expression in the cerebellum, we used maternal lipopolysaccharide (LPS)-exposed rat model of infection. In group 1, pregnant female rats were exposed to 200 μg/kg body weight LPS delivered subcutaneously from gestational days (G) 10 to G15, and pups were exposed to LPS from postnatal days (P) 5 to P10, whereas in group 2, pups were exposed to the same dose of LPS from P5 to P10. There was no change in body mass of pups and mothers following LPS treatment. Cerebellar NT-3 levels were examined by enzyme-linked immunosorbent assay on P6, P12, and P21. We report here that cerebellar NT-3 levels were elevated in pups of both LPS groups as compared to the controls on P21. Our results suggest that altered neurotrophin levels may affect normal brain development and contribute to autistic pathology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23319369     DOI: 10.1007/s12311-012-0446-7

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  12 in total

1.  Differential patterns of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 mRNA and protein levels in developing regions of rat brain.

Authors:  K P Das; S L Chao; L D White; W T Haines; G J Harry; H A Tilson; S Barone
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  Disrupting effects of hydroxy-polychlorinated biphenyl (PCB) congeners on neuronal development of cerebellar Purkinje cells: a possible causal factor for developmental brain disorders?

Authors:  Junko Kimura-Kuroda; Isao Nagata; Yoichiro Kuroda
Journal:  Chemosphere       Date:  2007-01-16       Impact factor: 7.086

3.  Maternal thimerosal exposure results in aberrant cerebellar oxidative stress, thyroid hormone metabolism, and motor behavior in rat pups; sex- and strain-dependent effects.

Authors:  Z L Sulkowski; T Chen; S Midha; A M Zavacki; Elizabeth M Sajdel-Sulkowska
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

4.  Increase in neurotrophin-3 expression followed by Purkinje cell degeneration in the adult rat cerebellum after spinal cord transection.

Authors:  H Kawakami; A Nitta; Y Matsuyama; M Kamiya; K Satake; K Sato; K Kondou; H Iwata; S Furukawa
Journal:  J Neurosci Res       Date:  2000-12-01       Impact factor: 4.164

5.  Hypoactivity of the central dopaminergic system and autistic-like behavior induced by a single early prenatal exposure to lipopolysaccharide.

Authors:  Thiago B Kirsten; Gabriela P Chaves-Kirsten; Lucas M Chaible; Ana C Silva; Daniel O Martins; Luiz R G Britto; Maria L Z Dagli; Andrea S Torrão; João Palermo-Neto; Maria M Bernardi
Journal:  J Neurosci Res       Date:  2012-06-20       Impact factor: 4.164

6.  Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism.

Authors:  Elizabeth M Sajdel-Sulkowska; Ming Xu; Noriyuki Koibuchi
Journal:  Cerebellum       Date:  2009-04-09       Impact factor: 3.847

7.  Cerebellar Purkinje cells are reduced in a subpopulation of autistic brains: a stereological experiment using calbindin-D28k.

Authors:  Elizabeth R Whitney; Thomas L Kemper; Margaret L Bauman; Douglas L Rosene; Gene J Blatt
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

8.  Lead-induced alterations of apoptosis and neurotrophic factor mRNA in the developing rat cortex, hippocampus, and cerebellum.

Authors:  Shirley L Chao; Jason M Moss; G Jean Harry
Journal:  J Biochem Mol Toxicol       Date:  2007       Impact factor: 3.642

9.  Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism.

Authors:  Stéphane J Baudouin; Julien Gaudias; Stefan Gerharz; Laetitia Hatstatt; Kuikui Zhou; Pradeep Punnakkal; Kenji F Tanaka; Will Spooren; Rene Hen; Chris I De Zeeuw; Kaspar Vogt; Peter Scheiffele
Journal:  Science       Date:  2012-09-13       Impact factor: 47.728

Review 10.  An assessment of the developmental, reproductive, and neurotoxicity of endosulfan.

Authors:  Marilyn H Silva; Derek Gammon
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2009-02
View more
  4 in total

1.  Neurotrophin blood-based gene expression and social cognition analysis in patients with autism spectrum disorder.

Authors:  Mònica Segura; Carla Pedreño; Jordi Obiols; Regina Taurines; Montserrat Pàmias; Edna Grünblatt; Alejandro Gella
Journal:  Neurogenetics       Date:  2014-12-24       Impact factor: 2.660

2.  Expression of mutant DISC1 in Purkinje cells increases their spontaneous activity and impairs cognitive and social behaviors in mice.

Authors:  Alexey V Shevelkin; Chantelle E Terrillion; Bagrat N Abazyan; Tymoteusz J Kajstura; Yan A Jouroukhin; Gay L Rudow; Juan C Troncoso; David J Linden; Mikhail V Pletnikov
Journal:  Neurobiol Dis       Date:  2017-04-06       Impact factor: 5.996

Review 3.  Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum.

Authors:  Alexey V Shevelkin; Chinezimuzo Ihenatu; Mikhail V Pletnikov
Journal:  Rev Neurosci       Date:  2014       Impact factor: 4.353

4.  Maternal Exposures Associated with Autism Spectrum Disorder in Jamaican Children.

Authors:  MacKinsey A Christian; Maureen Samms-Vaughan; MinJae Lee; Jan Bressler; Manouchehr Hessabi; Megan L Grove; Sydonnie Shakespeare-Pellington; Charlene Coore Desai; Jody-Ann Reece; Katherine A Loveland; Eric Boerwinkle; Mohammad H Rahbar
Journal:  J Autism Dev Disord       Date:  2018-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.